With more than 15 years of experience with different international companies and products we can bring you the right insights and the right strategy to get into Latin America markets.

Latin America is an attractive pharmaceutical market, with more than 300 mi inhabitants only in the 4 major markets – Argentina, Brazil, Colombia and Mexico.

The complexity of the health system in each of these markets and how they apply to your company and products is just one of the subjects we are prepared to unfold into a strategy tailored to your needs.

Latin America Market

With 20 countries and a population estimated in 654 million in 2020, Latin America has a great potential to grow in pharmaceutical, biotech market. In 2019 the nominal GDP was 5.7 trillion combined with 10.5 trillion GDP PPP.

The four major pharmaceutical markets are Brazil, Mexico, Argentina and Colombia, with a highlight to Brazil which is the 8th largest market globally, with an estimated value of 25 billion in 2019.

Source: World Bank, 2020

Empty section. Edit page to add content here.
Rank Country Sales 2019 (billions, US$) % Growth over 2018
1 United States 501.2 4.4
2 China* 94.9 9.1
3 Japan 79.0 2.3
4 Germany 51.9 6.7
5 France 35.2 2.9
6 Italy 32.9 3.0
7 United Kingdom 26.4 7.8
8 Spain 24.3 5.1
9 Brazil** 24.3 9.3
10 Canada 22.6 5.4

Notes: Prices are reported at the ex-manufacturer level (price when sold from manufacturer to wholesaler or direct to pharmacies).
* Hospital marketonly.
** Pharmacy market only. % growth, constant $.

Source: IQVIA MIDAS, MAT December 2019.

Rank Country Value of Pharmaceutical Market (in billions of $)
1 Brazil 34.25
2 Mexico 7.39
3 Argentina 4.68
4 Central America 1.94
5 Chile 1.75
6 Colombia 1.62
7 Ecuador 1.39
8 Peru 0.85
9 Dominican Republic 0.52
10 Paraguay 0.39

Source: Statista, 2020

The environment is complex and the health system differ from country to country, but as the numbers can show it is worth it. Latin America  currently represents 25% of the total pharmaceutical sales.

For pharmaceutical companies, Latin America is a strong bet for future growth. Brazil will continue to be the driver with 43% of the total LA market, followed by Mexico. The successful drug manufactures will continue to look to emerging markets as a source for their growth.

Biotech companies in Latin America

Several biotech companies have made an early movement to Latin America markets, from the pioneers Genzyme, Shire, Biogen and Amgen to Biomarin, Vertex, Ferring, Takeda and others.

The earlier you start the better for the results you aim.

Services

  1. General strategy to enter the Latin America Markets for pharmaceutical and devices;
  2. Tactics: Different paths to implement the strategy and the resources needed for it;
  3. Assistance to plan implementation – Execution;
  4. Specific assistance to an issue or situation – regulatory and market access;
  5. Education and training – regulatory and market access basic concepts on Latin America health care markets.

Brix Team

At Brix we have previously selected  a team of independent consultants with different skills and experiences that we allocate to the projects accordingly.

As soon as we get the scope of the project we talk to the consultants who we feel will fit better the project. We check their availability , willingness and costs. When we send the proposal to our clients we have the team figured out to run the project in a smooth and efficient way.

contact@brixconsulting.com.br     |     phone / whatsapp – +55 21 983 810 337